AHRR and neoplasm: These in vitro studies, using four molecular approaches (AHRR, siRNA, inducible shRNA, CRISPR/Ca9 gene editing) and two AHR-specific competitive inhibitors (CH223191, CB7993113), indicate that inhibition of AHR activity reduces two measures of tumor cell aggression, irregular colony growth characteristic of invasive cells and cell migration.